Presbia (OTCMKTS:LENSF) & Iradimed (NASDAQ:IRMD) Critical Analysis

Iradimed (NASDAQ:IRMD) and Presbia (OTCMKTS:LENSF) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, dividends and risk.

Risk and Volatility

Iradimed has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, Presbia has a beta of 5.91, indicating that its stock price is 491% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Iradimed and Presbia, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Iradimed	0	0	3	0	3.00
Presbia	0	0	0	0	N/A

Iradimed currently has a consensus price target of $60.00, indicating a potential upside of 30.95%. Given Iradimed’s higher probable upside, research analysts clearly believe Iradimed is more favorable than Presbia.

Earnings & Valuation

This table compares Iradimed and Presbia’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Iradimed	$69.48 million	8.35	$17.19 million	$1.41	32.50
Presbia	N/A	N/A	N/A	N/A	N/A

Iradimed has higher revenue and earnings than Presbia.

Insider & Institutional Ownership

92.3% of Iradimed shares are held by institutional investors. 42.6% of Iradimed shares are held by company insiders. Comparatively, 74.2% of Presbia shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Iradimed and Presbia’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Iradimed	26.83%	24.71%	20.86%
Presbia	N/A	N/A	N/A

Summary

Iradimed beats Presbia on 7 of the 9 factors compared between the two stocks.

About Iradimed

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

About Presbia

Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in the United States, South Korea, Australia, Italy, the Netherlands, Ireland, Canada, and Germany. The company was founded in 2014 and is headquartered in Dublin, Ireland.